Product Highlight - Ryzodeg Flextouch

29 Sep 2021
Product Highlight - Ryzodeg Flextouch
Active ingredient: 1 ml solution contains 100 units insulin degludec/insulin aspart in the ratio 70/30 (equivalent to 2.56 mg insulin degludec and 1.05 mg insulin aspart).
Indication: Diabetes mellitus in adults, adolescents and children from the age of 2 years.
Dosage & Administration: Individualized dosage. Once or twice daily with main meals.
• Patients with type 2 diabetes mellitus: Recommended total daily starting dose: 10 units with meals followed by individual dosage adjustments.
• Patients with type 1 diabetes mellitus: 60-70% of total daily insulin requirements once daily at mealtime in combination with short- or rapid-acting insulin at the remaining meals followed by individual dosage adjustments.

NOVO NORDISK PHARMA (THAILAND) LTD
98 Sathorn Square Office Tower, Unit 2101-2105, 21st Floor,
North Sathorn Rd. Silom Bangrak Bangkok 10500
Tel: (+66) 2237 9263-4 • Fax: (+66) 2237 9265

Related MIMS Drugs